CDKN1A and posterior cortical atrophy: CDKN1A acts as a potent cyclin-dependent kinase inhibitor, whereby its inhibition in PCa leads to cell cycle progression inhibition at G1 and induced G2 arrest (Baretton et al., 1999; Li et al., 2017).